טוען...
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
BACKGROUND: The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressi...
שמור ב:
| הוצא לאור ב: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020449/ https://ncbi.nlm.nih.gov/pubmed/27619909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0999-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|